Xenetic Biosciences posts investor video by CSO on DNase I oncology preclinical data

Xenetic Biosciences, Inc.

Chief Scientific Officer Curis Lockshin, PhD, discusses preclinical data from DNase I oncology platform.
Video available at https://www.virtualinvestorco.com/wtm-xbio-8k.
No financial results, guidance, or material business changes disclosed.

item 7.01

Xenetic Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-24-000866

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.